26772-1-AP
antibody from Proteintech Group
Targeting: IL24
C49A, FISP, IL-24, IL10B, mda-7, Mob-5, ST16
Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 26772-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- IL-24 antibody
- Antibody type
- Polyclonal
- Description
- IL-24 antibody (Cat. #26772-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Targeting PRSS23 with tipranavir induces gastric cancer stem cell apoptosis and inhibits growth of gastric cancer via the MKK3/p38 MAPK-IL24 pathway.
Serum IL-24 combined with CA125 as screening and prognostic biomarkers for NSCLC.
A systematic CRISPR screen reveals an IL-20/IL20RA-mediated immune crosstalk to prevent the ovarian cancer metastasis.
ZBTB7A Enhances Osteosarcoma Chemoresistance by Transcriptionally Repressing lncRNALINC00473-IL24 Activity.
Xiong JX, Li YT, Tan XY, Chen T, Liu BH, Fu L
Acta pharmacologica Sinica 2024 Feb;45(2):405-421
Acta pharmacologica Sinica 2024 Feb;45(2):405-421
Serum IL-24 combined with CA125 as screening and prognostic biomarkers for NSCLC.
Zhang K, Qu J, Deng S, Yuan E
Cell biology international 2024 Aug;48(8):1160-1168
Cell biology international 2024 Aug;48(8):1160-1168
A systematic CRISPR screen reveals an IL-20/IL20RA-mediated immune crosstalk to prevent the ovarian cancer metastasis.
Li J, Qin X, Shi J, Wang X, Li T, Xu M, Chen X, Zhao Y, Han J, Piao Y, Zhang W, Qu P, Wang L, Xiang R, Shi Y
eLife 2021 Jun 11;10
eLife 2021 Jun 11;10
ZBTB7A Enhances Osteosarcoma Chemoresistance by Transcriptionally Repressing lncRNALINC00473-IL24 Activity.
Zhang L, Wang Y, Li X, Xia X, Li N, He R, He H, Han C, Zhao W
Neoplasia (New York, N.Y.) 2017 Nov;19(11):908-918
Neoplasia (New York, N.Y.) 2017 Nov;19(11):908-918
No comments: Submit comment
No validations: Submit validation data